DirectBio

Curated by Signal

Provider of diagnostic assays utilizing AI-engineered CRISPR enzymes

Overview

Provider of diagnostic assays utilizing AI-engineered CRISPR enzymes. The company harness the speed, specificity, and sensitivity of natural and AI-engineered CRISPR enzymes to create diagnostic assays more scalable than conventional PCR.

Key facts

Founded: 2023
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

RUMI Scientific
Provider of proprietary human stem cell platform for screening genetic diseases
Life Sciences TechnologyNew York City, United States
HoloSurgical
Augmented reality surgical navigation and robotics technology
Life Sciences TechnologyChicago, United States
Chang Bioscience
Software for biology research
Life Sciences TechnologyCastro Valley, United States

About DirectBio

What does DirectBio do?

Provider of diagnostic assays utilizing AI-engineered CRISPR enzymes.

Where is DirectBio headquartered?

DirectBio is headquartered in San Francisco, United States.

When was DirectBio founded?

DirectBio was founded in 2023.

Which sector is DirectBio in?

DirectBio operates in Life Sciences Technology.

Who are DirectBio's competitors?

Companies similar to DirectBio include RUMI Scientific, HoloSurgical, and Chang Bioscience.